<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0372762</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3389</journal-id>
<journal-id journal-id-type="nlm-ta">Dev Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Dev. Biol.</journal-id>
<journal-title-group>
<journal-title>Developmental biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0012-1606</issn>
<issn pub-type="epub">1095-564X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28284905</article-id>
<article-id pub-id-type="pmc">5411011</article-id>
<article-id pub-id-type="doi">10.1016/j.ydbio.2017.03.007</article-id>
<article-id pub-id-type="manuscript">NIHMS859429</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Embryonic mosaic deletion of APP results in displaced Reelin-expressing cells in the cerebral cortex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Callahan</surname>
<given-names>DG</given-names>
</name>
<xref ref-type="author-notes" rid="FN2">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>WM</given-names>
</name>
<xref ref-type="author-notes" rid="FN2">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tilearcio</surname>
<given-names>M</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cavanaugh</surname>
<given-names>T</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Young-Pearse</surname>
<given-names>TL</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<aff id="A1">Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA</aff>
</contrib-group>
<author-notes>
<corresp id="FN1"><label>*</label>correspondence to: <email>tyoung@rics.bwh.harvard.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>1</label>
<p>These authors contributed equally to this study</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p><bold>Conflict of interest:</bold> The authors declare no competing financial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>4</month>
<year>2018</year>
</pub-date>
<volume>424</volume>
<issue>2</issue>
<fpage>138</fpage>
<lpage>146</lpage>
<!--elocation-id from pubmed: 10.1016/j.ydbio.2017.03.007-->
<abstract>
<p id="P2">It is widely accepted that amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer’s disease. In addition, APP has been proposed to have functions in numerous biological processes including neuronal proliferation, differentiation, migration, axon guidance, and neurite outgrowth, as well as in synapse formation and function. However, germline knockout of APP yields relatively subtle phenotypes, and brain development appears grossly normal. This is thought to be due in part to functional compensation by APP family members and other type I transmembrane proteins. Here, we have generated a conditional mouse knockout for APP that is controlled temporally using Cre<sup>ER</sup> and tamoxifen administration. We show that total cortical expression of APP is reduced following tamoxifen administration during embryonic time points critical for cortical lamination, and that this results in displacement of Reelin-positive cells below the cortical plate with a concurrent elevation in Reelin protein levels. These results support a role for APP in cortical lamination and demonstrate the utility of a conditional knockout approach in which <italic>APP</italic> can be deleted with temporal control <italic>in vivo</italic>. This new tool should be useful for many different applications in the study of APP function across the mammalian life span.</p>
</abstract>
<kwd-group>
<kwd>APP</kwd>
<kwd>Reelin</kwd>
<kwd>migration</kwd>
<kwd>Alzheimer’s</kwd>
<kwd>cortex</kwd>
<kwd>development</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>